43140 Federal Register / Vol. 74, No. 164 / Wednesday, August 26, 2009 / Notices 

Estimated Total Annual Burden 

Hours: 250 

Additional Information: 

Copies of the proposed collection may 

be obtained by writing to the 

Administration for Children and 

Families, Office of Administration, 

Office of Information Services, 370 

L’Enfant Promenade, SW., Washington, 

DC 20447, Attn: ACF Reports Clearance 

Officer. All requests should be 

identified by the title of the information 

collection. E-mail address: 

infocollection@acf.hhs.gov. 

OMB Comment: 

OMB is required to make a decision 

concerning the collection of information 

between 30 and 60 days after 

publication of this document in the 

Federal Register. Therefore, a comment 

is best assured of having its full effect 

if OMB receives it within 30 days of 

publication. Written comments and 

recommendations for the proposed 

information collection should be sent 

directly to the following: Office of 

Management and Budget, Paperwork 

Reduction Project, Fax: 202–395–7245, 

Attn: Desk Officer for the 

Administration for Children and 

Families. 

Dated: August 21, 2009. 

Robert Sargis, 

Reports Clearance Officer. 

[FR Doc. E9–20547 Filed 8–25–09; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; 

Comment Request 

Title: Summary Data Component, 

National Child Abuse and Neglect Data 

System (NCANDS). 

OMB No.: 0980–0229. 

Description: The Child Abuse and 

Neglect Treatment Act (42 U.S.C. 5101 

et seq.) as amended requires States to 

annually work with the Secretary to 

provide to the maximum extent 

practical, a report that includes 12 data 

items listed in the statute. The National 

Child Abuse and Neglect Data System 

(NCANDS), administered by the 

Children’s Bureau, meets this reporting 

requirement. In addition, the 

amendments of 1988 require that the 

data system shall be universal and case 

specific and integrated with other casebased foster care and adoption data 

collected by the Secretary. There are 

two data components, the Detailed Case 

Data Component (DCDC), which 

includes the case-level data submitted 

through the Child File and some 

aggregated data submitted through the 

Agency File, and the Summary Data 

component (SC), which is used by 

States that cannot submit case-level 

data. No changes are being requested. 

The Summary Data Component will be 

phased out over the next few years as 

the number of States that can complete 

the Child File increases. 

Respondents: State Child Welfare 

Agencies. 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of responses per 

respondent 

Average burden hours per 

response 

Total burden 

hours 

Child File .......................................................................................................... 50 1 80 4,000 

Agency File ...................................................................................................... 50 1 24 1,200 

Summary Data Component (SDC) .................................................................. 2 1 32 64 

Estimated Total Annual Burden 

Hours: 5,264. 

Additional Information 

Copies of the proposed collection may 

be obtained by writing to the 

Administration for Children and 

Families, Office of Administration, 

Office of Information Services, 370 

L’Enfant Promenade, SW., Washington, 

DC 20447, Attn: ACF Reports Clearance 

Officer. All requests should be 

identified by the title of the information 

collection. E-mail address: 

infocollection@acf.hhs.gov. 

OMB Comment 

OMB is required to make a decision 

concerning the collection of information 

between 30 and 60 days after 

publication of this document in the 

Federal Register. Therefore, a comment 

is best assured of having its full effect 

if OMB receives it within 30 days of 

publication. Written comments and 

recommendations for the proposed 

information collection should be sent 

directly to the following: 

Office of Management and Budget, 

Paperwork Reduction Project. Fax: 202– 

395–7245. Attn: Desk Officer for the 

Administration for Children and 

Families. 

Dated: August 21, 2009. 

Robert Sargis, 

Reports Clearance Officer. 

[FR Doc. E9–20546 Filed 8–25–09; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2009–N–0383] 

Request for Notification From Industry 

Organizations Interested in 

Participating in the Selection Process 

for a Nonvoting Industry 

Representative on the Tobacco 

Products Scientific Advisory 

Committee and Request for 

Nominations for a Nonvoting Industry 

Representative on the Tobacco 

Products Scientific Advisory 

Committee 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is requesting that 

any industry organizations interested in 

participating in the selection of a 

nonvoting industry representative to 

serve on its Tobacco Products Scientific 

Advisory Committee notify FDA in 

writing. A nominee may either be selfnominated or nominated by an 

organization to serve as a nonvoting 

industry representative. Nominations 

will be accepted for current vacancies 

effective with this notice. Elsewhere in 

this issue of the Federal Register, FDA 

is publishing two separate documents 

announcing the establishment of the 

committee and the request for 

nomination of the Tobacco Products 

Scientific Advisory Committee. 

DATES: Any industry organization 

interested in participating in the 

selection of an appropriate nonvoting 

member to represent industry interests 

must send a letter stating the interest to 

FDA by September 25, 2009, for 

vacancies listed in the notice. 

Concurrently, nomination material for 


jlentini on DSKJ8SOYB1PROD with NOTICES
Federal Register / Vol. 74, No. 164 / Wednesday, August 26, 2009 / Notices 43141 

prospective candidates should be sent to 

FDA by September 25, 2009. 

ADDRESSES: All nominations for 

membership should be sent 

electronically to cv@oc.fda.gov, or by 

mail to Advisory Committee Oversight & 

Management Staff, 5600 Fishers Lane 

(HF–4), rm. 14C03, Rockville, MD 

20857. 

FOR FURTHER INFORMATION CONTACT: Erik 

P. Mettler, Office of Policy, Office of the 

Commissioner, Food and Drug 

Administration, 10903 New Hampshire 

Ave., Bldg. 1, rm. 4324, Silver Spring, 

MD 20993, 301–796–4711, FAX: 301– 

847–3541, e-mail: 

erik.mettler@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

agency requests nominations for 

nonvoting industry representatives on 

the Tobacco Products Scientific 

Advisory Committee. Elsewhere in this 

issue of the Federal Register, FDA is 

publishing two separate documents 

announcing the establishment of the 

committee and the request for 

nomination of the Tobacco Products 

Scientific Advisory Committee. 

I. Center for Tobacco 

Tobacco Products Scientific Advisory 

Committee 

The Tobacco Products Scientific 

Advisory Committee advises the 

Commissioner or designee in 

discharging responsibilities as they 

relate to the regulation of tobacco 

products. The Committee reviews and 

evaluates safety, dependence, and 

health issues relating to tobacco 

products and provides appropriate 

advice, information, and 

recommendations to the Commissioner 

of Food and Drugs. 

The Committee shall include three 

nonvoting members who are identified 

with industry interests. These members 

shall include one representative of the 

tobacco manufacturing industry, one 

representative of the interests of tobacco 

growers, and one representative of the 

interests of the small business tobacco 

manufacturing industry. This final 

position can be filled on a rotating, 

sequential basis by representatives of 

different small business tobacco 

manufacturers based on areas of 

expertise relevant to the topics being 

considered by the Committee. 

II. Selection Procedure 

Any industry organization interested 

in participating in the selection of an 

appropriate nonvoting member to 

represent industry interests should send 

a letter stating that interest to the FDA 

contact (see FOR FURTHER INFORMATION

CONTACT) within 30 days of publication 

of this document. Within the 

subsequent 30 days, FDA will send a 

letter to each organization that has 

expressed an interest, attaching a 

complete list of all such organizations; 

and a list of all nominees along with 

their current resumes. The letter will 

also state that it is the responsibility of 

the interested organizations to confer 

with one another and to select a 

candidate, within 60 days after the 

receipt of the FDA letter, to serve as the 

nonvoting member to represent industry 

interests for the Tobacco Products 

Scientific Advisory Committee. The 

interested organizations are not bound 

by the list of nominees in selecting a 

candidate. However, if no individual is 

selected within 60 days, the 

Commissioner of Food and Drugs will 

select the nonvoting member to 

represent industry interests. 

III. Application Procedure 

Individuals may self nominate and/or 

an organization may nominate one or 

more individuals to serve as a nonvoting 

industry representative. A current 

curriculum vitae and the name of the 

committee of interest should be sent to 

the FDA contact person within the 30 

days. FDA will forward all nominations 

to the organizations expressing interest 

in participating in the selection process 

for the committee. (Persons who 

nominate themselves as nonvoting 

industry representatives will not 

participate in the selection process). 

FDA has a special interest in ensuring 

that women, minority groups, 

individuals with physical disabilities, 

and small businesses are adequately 

represented on its advisory committees, 

and therefore, encourages, nominations 

for appropriately qualified candidates 

from these groups. 

This notice is issued under the 

Federal Advisory Committee Act (5 

U.S.C. app. 2) and 21 CFR part 14, 

relating to advisory committees. 

Dated: August 19, 2009. 

David Horowitz, 

Assistant Commissioner for Policy. 

[FR Doc. E9–20483 Filed 8–25–09; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2009–N–0664] 

Industry Exchange Workshop on Food 

and Drug Administration Drug and 

Device Requirements; Public 

Workshop 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of public workshop. 

SUMMARY: The Food and Drug 

Administration (FDA) Philadelphia 

District, in cosponsorship with the 

Society of Clinical Research Associates 

(SoCRA) is announcing a public 

workshop entitled: ‘‘FDA Clinical Trial 

Requirements, Regulations, Compliance 

and GCP.’’ This 2-day public workshop 

is intended to provide information 

about FDA clinical trial requirements to 

the regulated industry. 

Date and Time: The public workshop 

will be held on October 21, 2009, from 

8:30 a.m. to 5 p.m. and October 22, 

2009, from 8:30 a.m. to 5 p.m. 

Location: The public workshop will 

be held at the Hyatt Regency Pittsburgh 

International Airport, 1111 Airport 

Blvd., Pittsburgh, PA 15231, 724–899– 

1234 or 1–800–233–1234. 

Attendees are responsible for their 

own accommodations. To make 

reservations at the Hyatt Regency Hotel, 

contact the Hyatt Regency Hotel. 

Contact: Marie Falcone, Food and 

Drug Administration, U.S. 

Customhouse, 200 Chestnut St., rm. 900, 

Philadelphia, PA 19106, 215–717–3703, 

FAX: 215–597–4660, e-mail: 

marie.falcone@fda.hhs.gov. 

Registration: You are encouraged to 

register by October 19, 2009. The 

SoCRA registration fees cover the cost of 

facilities, materials, and breaks. Seats 

are limited; please submit your 

registration as soon as possible. Course 

space will be filled in order of receipt 

of registration. Those accepted in to the 

course will receive confirmation. 

Registration will close after the course is 

filled. Registration at the site is not 

guaranteed but may be possible on a 

space available basis on the day of the 

public workshop beginning at 8 a.m. 

The cost of registration is as follows: 

COST OF REGISTRATION

Affiliation Fee 

FDA Employee Fee Waived 

Government (Non-Member) $525.00 


jlentini on DSKJ8SOYB1PROD with NOTICES